Our objective was to compare postoperative pain scores between women who underwent cesarean delivery (CD) and were discharged home on a regimen of either ibuprofen/acetaminophen (non-opioid group) or ibuprofen/acetaminophen plus hydrocodone (opioid group). STUDY DESIGN: We conducted a single center open-labeled, comparative effectiveness, equivalence trial from 12/2017 to 03/2018. Women with CD, over 18 years old were included. Before hospital discharge, women were randomized to prescriptions for non-opioid (ibuprofen 600 mg every 6 hours plus acetaminophen 325 mg, 1 or 2 tablets every 4 hours) or opioid (ibuprofen 600 mg every 6 hours plus hydrocodone/acetaminophen 5/325 mg tabs, 1 or 2 tabs every 4 hours). If a patient felt her pain was not adequately controlled, they could get a rescue opioid prescription. The primary outcome was pain score at 2-4 weeks after discharge recorded on a visual analogue scale (VAS). Treatments were considered equivalent if the bounds of the 95% CI for the group difference in mean pain score are between -10 to 10 mm. Sample size calculation revealed that 128 women were needed to reject the non-equivalence hypothesis (80% power; twosided alpha of 0.05). To adjust for 30% follow up attrition rate in our population, 170 women needed to be randomized. Analysis was by intent to treat. (ClinicalTrials.gov NCT03372382) RESULTS: Of 170 women randomized, the primary outcome was available in 149 (88%). Compared to non-opioid group, the mean VAS pain score was higher (worse) in opioid group (12.36 AE 19.55 vs 15.93 AE 20.45 mm, adjusted mean difference 4.89, 95% CI -2.19 to 11.96). Since the CI upper limit is >10mm treatments are not equivalent, meaning that the opioid group had a pain score that was clinically significantly higher. Patient satisfaction was similar between groups. The number of previous CD did not influence VAS score (IRR 1.07, CI 0.9e1.2) or patient satisfaction (aOR 1.18, CI 0.65e2.15).Women in the opioid group experienced drug related side effects more frequently, including somnolence and constipation (14 vs 25, p 0.05) CONCLUSION: In women with CD, pain score at 2-4 weeks postpartum was lower in those receiving non-opioid analgesics than in those receiving opioid analgesia. Adding opioids to a regimen of ibuprofen and acetaminophen for outpatient analgesia after CD, increases the likelihood of drug related side effects and it does not improve pain score or patient satisfaction after discharge.
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